Nephropharmacology: Drugs and the Kidney

被引：15

作者：

Atkinson, A. J., Jr. ^{[1
]}

Huang, S-M ^{[2
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biochem, Chicago, IL 60611 USA

[2] US FDA, Off Clin Pharmacol, Ctr Drug Evaluat & Res, Silver Spring, MD USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2009年 / 86卷 / 05期

关键词：

DISEASE; IMPACT;

D O I：

10.1038/clpt.2009.191

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：453 / 456

页数：4

共 20 条

[1] Pharmacokinetic Studies in Hemodialysis Patients [J].

Atkinson, A. J., Jr. ;

Umans, J. G. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (05) :548-552

[2]

Atkinson AJ, 2007, PRINCIPLES OF CLINICAL PHARMACOLOGY, 2ND EDITION, P51, DOI 10.1016/B978-012369417-1/50045-6

[3] Drug Dosing in Patients With Impaired Renal Function [J].

Brater, D. C. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (05) :483-489

[4] NEPHRON ADAPTATION TO RENAL INJURY OR ABLATION [J].

BRENNER, BM .

AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 249 (03) :F324-F337

[5] INDIVIDUALIZATION OF DRUG DOSAGE IN PATIENTS WITH RENAL-DISEASE [J].

DETTLI, L .

MEDICAL CLINICS OF NORTH AMERICA, 1974, 58 (05) :977-985

[6] The Influence of Chronic Renal Failure on Drug Metabolism and Transport [J].

Dreisbach, A. W. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (05) :553-556

[7] Novel Biomarkers of Acute Kidney Toxicity [J].

Goodsaid, F. M. ;

Blank, M. ;

Dieterle, F. ;

Harlow, P. ;

Hausner, E. ;

Sistare, F. ;

Thompson, A. ;

Vonderscher, J. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (05) :490-496

[8] Dialysis at a crossroads: Reverse engineering renal replacement therapy [J].

Himmelfarb, Jonathan .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (04) :896-902

[9] Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice [J].

Huang, S-M ;

Temple, R. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (03) :287-294

[10] When to Conduct a Renal Impairment Study During Drug Development: US Food and Drug Administration Perspective [J].

Huang, S-M ;

Temple, R. ;

Xiao, S. ;

Zhang, L. ;

Lesko, L. J. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (05) :475-479

← 1 2 →